New Ozempic pill now available in the U.S.

• Novo Nordisk introduced its rebranded oral semaglutide capsule, Rybelsus, will quickly be obtainable because the ‘Ozempic capsule’ following a formulation change.
• The smaller, reformulated capsule shall be obtainable in several dosages than the Rybelsus capsule, with Novo Nordisk stating it gives the identical efficacy and security profile as the unique formulation.
• The healthcare firm additionally states that the Ozempic capsule shall be obtainable nationwide by means of pharmacies, telehealth, and mail-order providers.
• Pricing is predicted to range by protection, with insured sufferers doubtlessly paying $25 for as much as 3 months, whereas self-pay choices are estimated between $149 and $299 monthly relying on dose.

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that mimics a hormone to extend insulin secretion, gradual gastric emptying, and scale back urge for food.

The medicine has Meals and Drug Administration (FDA) approval for serving to with long-term weight administration and treating type 2 diabetes.

For many individuals, semaglutide is best often called the injectable drug Ozempic. Nevertheless, many will not be conscious that semaglutide has been obtainable in oral type because it was permitted by the FDA in 2019.

After beforehand saying a rebrand and reformulation to Rybelsus in February 2026 to make the therapy extra simply recognizable and bioavailable, Novo Nordisk introduced that the “Ozempic pill” shall be obtainable for adults with sort 2 diabetes in the US beginning Monday, Might 4, 2026.

Highlighting that the oral capsule will help enhance blood glucose management alongside weight-reduction plan and train, whereas additionally lowering main cardiovascular occasions in adults with sort 2 diabetes at elevated threat, the pharmaceutical firm provides that the capsule shall be obtainable by means of 70,000+ U.S. pharmacies nationwide and choose telehealth suppliers.

The oral capsule was designed to assist enhance blood glucose management alongside weight-reduction plan and train, whereas additionally providing further cardiometabolic advantages in sure excessive threat sufferers.

Now rebranded because the Ozempic capsule, the up to date formulation is obtainable in several strengths of 1.5 mg, 4 mg, and 9 mg. Within the press launch, Novo Nordisk states that the Ozempic capsule formulation is extra bioavailable and works equally to the Rybelsus tablets, providing the identical efficacy and security profile as the unique formulation, however in a smaller capsule.

The pharmaceutical firm provides that individuals ought to take the brand new formulation the same way as earlier than, in order that individuals who had been taking 3 mg ought to now take 1.5 mg, and so forth.

Whereas each injectable Ozempic and oral Rybelsus include semaglutide and have approval for sort 2 diabetes, Novo Nordisk recommend the model identify Ozempic is extra synonymous with GLP-1 medicines, therefore the rename.

“Whereas the oral type of semaglutide has been obtainable for years as Rybelsus, the Ozempic branding is extra well known, which can result in elevated affected person requests,” Mir Ali, MD, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Middle at Orange Coast Medical Middle in Fountain Valley, CA, informed Medical Information At this time.

“Moreover, as a result of the oral type has an extended shelf life, it might supply logistical benefits for sure prescribing patterns,” Ali defined.

The selection between oral and injectable formulations is often all the way down to particular person components and preferences. It’s advisable for an individual to debate choices with their healthcare skilled.

Typically, analysis means that injectable semaglutide achieves significantly better HbA1c reductions in comparison with oral types in these with sort 2 diabetes.

Moreover, whereas the day by day oral type could also be preferable to weekly injections, analysis means that adversarial occasions happen more frequently with oral semaglutide.

Talking to MNT, Ali famous the potential benefits and downsides of oral GLP-1 medicines:

“The first benefits of oral GLP-1 medicines are that they’re simpler to take, transport, and retailer. They’re additionally sometimes cheaper to fabricate, which might result in decrease prices for sufferers. The disadvantages are that they’re barely much less efficient than injections and require day by day as an alternative of weekly administration.”

Novo Nordisk additionally outlined pricing preparations they recommend will enhance entry to the Ozempic capsule. For insured people, the medicine could also be obtainable for $25 for as much as a 3-month provide.

Self-pay choices, obtainable by means of Novo Nordisk’s pharmacy and choose telehealth suppliers, are anticipated to vary from roughly $149 to $299 monthly, relying on dose power, defining a month’s provide as one bottle of 30 capsules.

This will likely supply a less expensive different to injectable Ozempic, as whereas a 3-month provide may additionally be obtainable for $25, self-pay sufferers can expect to pay $349 monthly for doses as much as 1 mg and $499 for the two mg dose.

“Pricing and insurance coverage protection are vital components in medicine adherence,” Ali informed MNT.

“Excessive out-of-pocket bills make sufferers much less more likely to search or preserve therapy. Consequently, if prices stay excessive, people in decrease socioeconomic areas with restricted well being protection will face vital limitations to accessing these medicines,” he added.

The rebrand of the Ozempic capsule could replicate a broader shift in diabetes care towards GLP-1–based mostly therapies, with the FDA approving Foundayo, an oral GLP-1 receptor agonist from Eli Lily, in April 2026.

Whereas GLP-1-based therapies have historically been administered by way of injection, the oral formulations intention to offer a extra handy different for many who desire to not use injectable medicines.

Novo Nordisk provides that the capsule is manufactured end-to-end within the U.S. and shall be extensively distributed by means of established pharmacy networks. Additionally they notice that that is the primary time oral semaglutide for sort 2 diabetes is being provided by means of their direct-to-patient service.

“Accessibility is vital, particularly as these medicines are in excessive demand and have confronted shortages,” Ali highlights. “Lack of entry typically leads sufferers to modify to much less efficient options or discontinue therapy fully.”

Past blood sugar management, Novo Nordisk additionally states that the Ozempic capsule can be permitted for lowering the danger of main cardiovascular occasions, together with heart attack, stroke, or dying, in adults with sort 2 diabetes who’re at elevated threat.

“Actual-world cardiovascular advantages are linked to weight reduction, improved blood strain, and decreased irritation,” Ali notes. “Some research have proven a discount in main adversarial cardiovascular occasions by 18-20%. Sufferers with diabetes, weight problems, and present atherosclerotic heart problems stand to learn essentially the most.”